High incidence of venous thrombosis in patients with moderate-to-severe COVID-19중등도에서 중증의 COVID-19 환자에서 정맥 혈전증의 높은 발병률Article Published on 2021-03-012022-09-11 Journal: International journal of hematology [Category] SARS, 바이오마커, [키워드] Anticoagulants anticoagulation anticoagulation therapy clinical information Computerized tomography consecutive patient COVID-19 critical COVID-19 patients deep-vein thrombosis DVT Evidence females Follow-up hospital discharge incidence Increasing lab lab data less lung majority male moderate-to-severe COVID-19 Patient patients Prevalence Severe patient subject therapy thrombi thrombosis Treatment Venous Thromboembolism Venous thrombosis [DOI] 10.1007/s12185-020-03061-y PMC 바로가기 [Article Type] Article
Validation of two severity scores as predictors for outcome in Coronavirus Disease 2019 (COVID-19)Observational Study Published on 2021-02-192022-10-04 Journal: PLoS ONE [Category] MERS, 임상, [키워드] acute respiratory distress adjusted hazard ratio Admission Clinical severity complications COVID-19 Cox regression died Disease progression enrolled Hospitalization identify independent predictor independent risk factor initial mechanical ventilation Mortality multivariate myocardial injury occurred outcome Patient patients patients hospitalized predict predictor presenting progression reported Result retrospective risk secondary endpoint severity Severity Score Stage stages stroke syndrome tested the primary endpoint validation Venous thrombosis was used with COVID-19 [DOI] 10.1371/journal.pone.0247488 PMC 바로가기 [Article Type] Observational Study
Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic reviewArticle Published on 2021-02-142022-10-30 Journal: Journal of Thrombosis and Thrombolysis [Category] COVID-19, MERS, [키워드] addressed Anticoagulant anticoagulation clinical suspicion Cohort Complication conducted coronavirus Critical care Deep venous thrombosis demographics Diagnosis dose Embolism high mortality hospitalized patients ICU identify incidence Intensive intensive care management observational study occurred outcomes Patient patients patients with COVID-19 Prevalence Prospective trial prothrombotic state recommendation reported Severe COVID-19 Infection severe disease significantly higher supplementary material systematic review Thromboembolism Thromboprophylaxis thrombosis thrombotic complication Thrombotic complications Thrombotic events treated venous Venous thrombosis [DOI] 10.1007/s11239-021-02394-7 PMC 바로가기 [Article Type] Article
Case Report: Concomitant Massive Cerebral Venous Thrombosis and Internal Iliac Vein Thrombosis Related to Paucisymptomatic COVID-19 InfectionNeurology Published on 2021-02-102022-11-01 Journal: Frontiers in Neurology [Category] COVID-19, [키워드] Active surveillance Admission Affect anticoagulation Asymptomatic cerebral Cerebral venous thrombosis Clinical course Complication Concomitant COVID-19 COVID-19 infection COVID-19 patients CT scan Fever Galen headache Hypoxemia Infection internal internal iliac vein thrombosis interstitial pneumonia late phase low molecular weight malignancy massive neurologic neurological deficits outcome Patient Pelvic repeated respiratory symptoms SARS-CoV-2 SARS-COV-2 infection serological test silent subarachnoid hemorrhage Support Swab tested Thromboinflammation thrombosis thrombotic complication treated Treatment unfractionated heparin Vein venous Venous thrombosis with COVID-19 [DOI] 10.3389/fneur.2021.622130 PMC 바로가기 [Article Type] Neurology
A Case Report of Cerebral Venous Thrombosis as a Complication of Coronavirus Disease 2019 in a Well-appearing PatientCOVID-19 Case Report Published on 2021-02-072022-10-31 Journal: Clinical Practice and Cases in Emergency Medicine [Category] COVID-19, [키워드] anticoagulation cerebral Cerebral venous thrombosis Complication COVID-19 COVID-19 patient diagnosed discharge headache healthy initiated Inpatient male Patient positive COVID-19 report resolved risk risk factor SARS-CoV-2 severe coronavirus disease stroke Symptom thromboembolic disease thrombotic complication Thrombotic complications Venous thrombosis while [DOI] 10.5811/cpcem.2020.11.49633 PMC 바로가기 [Article Type] COVID-19 Case Report
Haemostatic and thrombo-embolic complications in pregnant women with COVID-19: a systematic review and critical analysisCOVID-19에 감염된 임산부의 지혈 및 혈전 색전증 합병증: 체계적인 검토 및 비판적 분석Research Article Published on 2021-02-052022-09-10 Journal: BMC Pregnancy and Childbirth [Category] MERS, 치료기술, [키워드] 95% CI abnormal coagulation affected analysed Analysis arterial or venous thrombosis Arterial thrombosis Birth Case report case reports clinical evidence clinical suspicion Coagulation coagulation test Coagulopathy Complication COVID-19 Critical database death Definition detection Deterioration diagnosis of COVID-19 Disseminated intravascular coagulation Disseminated intravascular coagulopathy evidence of Factor Haematological complications inclusion criteria increased risk information intravascular coagulation laboratory result Laboratory results maternal deaths outcome patients performed physiological positive swab pregnancies Pregnancy pregnant women prothrombotic state reported Result risk SARS-CoV-2 searched Seven step supplementary material Swab systematic review thromboembolic thromboembolic complication thromboembolic complications Thromboembolism thrombosis Venous thrombosis with COVID-19 women [DOI] 10.1186/s12884-021-03568-0 PMC 바로가기 [Article Type] Research Article
A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trialCOVID19에 감염된 종양-혈액학적 환자에서 호흡 부전 진행을 예방하기 위한 바리시티닙의 효능을 평가하기 위한 I/II상 임상 시험: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2021-02-052022-09-10 Journal: Trials [Category] MERS, 임상, 치료제, [키워드] 1:1 AAK1 absence activator Acute respiratory failure Administered administration Adverse adverse events affected alkaline phosphatase All participants allergy Alpha alpha error angina pectoris Antibiotics appearance ARDS Arm assigned AST/ALT Baricitinib baseline beta error Bilirubin Blinding Blood Breastfeeding can be used candidate Candidates capture Cardiac arrhythmia carried change clearance clinical clinical condition clinical suspicion clinical trials Coagulation Cohort Common Terminology Criteria Comorbidity Complete completion Compliance congestive heart failure control arm Controlled trial corticoid Corticosteroids COVID19 creatinine creatinine clearance CRP D-dimer Day Deep venous thrombosis description Deterioration Dexamethasone dimer discharge discretion disease dissemination diverticulitis dose dropout rate Duration of therapy ECMO Efficacy electronic case report form element eligibility criteria Enrollment evaluate exclusion criteria expected experimental arm extracorporeal membrane oxygenation febrile neutropenia ferritin followed by form fraction Gas exchange greater HBV HCV hemodynamic instability High-flow nasal cannula HIV HIV infection ICU immobilization immunological impossibility incidence include indication Infection infection with SARS-CoV-2 Inflammatory response interfere interferon Interim interim analysis interleukin interleukin 6 interstitial pneumonia Intervention intestinal perforation Invasive mechanical ventilation investigational agent investigator jak inhibitors Jak-STAT Laboratory laboratory parameter Laboratory parameters LDH less limit limits management mechanical ventilation medical history Medicine meet Methylprednisolone Mild ARDS Mortality multi organ failure nasal nasal cannula need for oxygen neutropenia neutrophil Neutrophils Non-invasive number objective on mechanical ventilation oncological patients onset of symptom open open label oral medication organ dysfunction Organ failure outcome oxygen oxygen support PaFi participant Participants Participation pathogen Pathogens pathway Patient patients performance status performed phase Phase 1 Phase 2 Phase I phosphatase platform Pneumonia poor prognosis positive Prednisone pregnancy test pregnant prejudice Prevent progression Prophylaxis Protein protein kinase protocol Psychiatric psychiatric illness Pulmonary embolism radiological randomisation randomised randomised controlled trial randomization Randomized Randomized controlled trial receive receptor recruitment REDCap REDcap platform reduce reduced Remdesivir removal report reported required respiratory Respiratory failure Respiratory function respiratory insufficiency respiratory tract Sample size SARS-CoV-2 SARS-CoV2 SARS-CoV2 infection Secondary objectives Sepsis severe adverse event severe adverse events severe pneumonia severe respiratory failure Spain Spanish Standard of care STAT status study enrollment Study protocol supplemental oxygen requirement supplemental oxygen requirements supplementary material Support surgical surgical intervention Symptom symptomatic Tablet Therapies therapy thromboembolic disease thrombosis Tocilizumab total bilirubin Toxicity Transcription transducer Treatment treatment period Trial unstable angina use of corticosteroid Venous thrombosis Version viral endocytosis website Withdrawal worsening [DOI] 10.1186/s13063-021-05072-4 PMC 바로가기 [Article Type] Letter
Neutrophil extracellular traps and thrombosis in COVID-19Comparative Study Published on 2021-02-012023-07-12 Journal: Journal of Thrombosis and Thrombolysis [Category] SARS, [키워드] Blood coagulation calprotectin COVID-19 extracellular traps Neutrophils Venous thrombosis [DOI] 10.1007/s11239-020-02324-z PMC 바로가기 [Article Type] Comparative Study
Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID-19 while we are awaiting the results of clinical trials?논란: 코로나19 환자에서 임상 결과를 기다리는 동안 정맥 혈전증 예방을 위한 항응고제의 용량이나 기간을 늘려야 할까?Article Published on 2021-02-012022-09-11 Journal: British Journal of Haematology [Category] SARS, 임상, [키워드] Abstract Anticoagulant anticoagulation clinical trials coronavirus coronavirus disease Coronavirus disease 2019 dose patients with COVID-19 Thromboprophylaxis thrombosis Venous thrombosis [DOI] 10.1111/bjh.17241 PMC 바로가기 [Article Type] Article
Risk Management and Treatment of Coagulation Disorders Related to COVID-19 InfectionCOVID-19 감염과 관련된 응고 장애의 위험 관리 및 치료Review Published on 2021-01-312022-09-12 Journal: International Journal of Environmental Research an [Category] 진단, [키워드] abnormality Activation Acute respiratory failure admitted to ICU anticoagulation appear approach Bilateral bilateral pneumonia bleeding Coagulation Coagulopathy coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient D-dimer level D-dimer levels Deep vein thrombosis Deep venous thrombosis described Diagnosis disease dose Efficacy and safety Emerging infectious disease Endothelial dysfunction events Evidence feasible feature fibrinogen Frequency individuals with COVID-19 Infectious disease Inpatient institutional protocol intensive care intensive care unit less management Microvascular thrombosis occur overlap Patient Pneumonia Prevent prophylactic dose pulmonary Pulmonary embolism receive Respiratory failure risk severe COVID-19 Symptom systemic inflammation the disease therapeutic therapeutic dose threshold thromboembolic thromboembolic complication thromboembolic complications Thromboembolism Thromboprophylaxis thrombosis thrombotic treat Treatment Venous Thromboembolism Venous thrombosis with COVID-19 [DOI] 10.3390/ijerph18031268 PMC 바로가기 [Article Type] Review